Biosimilar Policy White Paper – A4 Flyer
An evidence-led A4 flyer outlining the current state of biosimilar access policies in Australia and the opportunity for reform. It highlights key challenges, international comparisons, and recommended policy changes to improve affordability, increase uptake, and drive sustainable PBS savings. Designed for policymakers and healthcare stakeholders, it presents clear, data-driven insights to support informed decision-making and advocate for system-wide impact.

Leadtime:

• Production: 3-4 working days
• Delivery 3-6 working days